Ameriprise’s Oruka Therapeutics ORKA Stock Holding History

Ameriprise’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-7	Closed	-$12K	–	4466
2014 Q3	$12K	Buy	+7	New	+$14.6K	﹤0.01%	4750

Other funds holding ORKA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Ameriprise's ORKA Position: Q4 2014 in Review

Ameriprise sold out of Oruka Therapeutics (ORKA) in Q4 2014, closing a stake of 7 shares — an estimated $12K sold.

Ameriprise first reported a position in ORKA in Q3 2014 and held it in 1 quarter. The position peaked at $12K in Q3 2014. 11 funds tracked by Wall St. Rank hold ORKA as of Q4 2014.

Ameriprise reported no remaining Oruka Therapeutics position as of Q4 2014 after selling out during the quarter.
Ameriprise sold 7 Oruka Therapeutics shares in Q4 2014, an estimated $12K.
Ameriprise first reported a position in Oruka Therapeutics in Q3 2014 and held it in 1 quarter.
Ameriprise's Oruka Therapeutics position peaked at $12K in Q3 2014.
11 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.